FDA OKs diabetes drug combo Jentadueto

01/30/2012 | Wall Street Journal, The

Eli Lilly and Co. and Boehringer Ingelheim received FDA approval for Jentadueto, a type 2 diabetes medicine intended for use with exercise and diet. The oral treatment, which combines linagliptin and metformin hydrochloride, can be taken alone or with commonly prescribed sulfonylurea.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL